Login / Signup

Cerebrospinal Fluid Levels of Kininogen-1 Indicate Early Cognitive Impairment in Parkinson's Disease.

Ioanna MarkakiSofia BergströmPanagiota TsitsiJulia RemnestålAnna MånbergEllen HertzWojciech PaslawskiKimmo SorjonenMathias UhlénGraziella MangoneStephanie CarvalhoOlivier RascolWassillios G MeissnerEloi MagninUllrich WüllnerJean-Christophe CorvolPeter NilssonPer Svenningsson
Published in: Movement disorders : official journal of the Movement Disorder Society (2020)
Kininogen-1 levels in CSF may serve as a marker of cognitive impairment in PD. © 2020 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Keyphrases
  • cognitive impairment
  • cerebrospinal fluid
  • randomized controlled trial
  • systematic review